Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

How does the cost of applying for a “Listed Seller of Poisons” licence compare with that of applying for a “Pharmacy” licence?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q269 · Category F: Fees, Budget and Financial Planning (Q251-Q300)
The cost of applying for a “Listed Seller of Poisons” (LSP) licence is usually much lower than that of applying for an “Authorised Seller of Poisons” (Pharmacy) licence. The main differences are: 1. “Government fees”: the LSP application fee and annual fee (currently HKD$455) are significantly lower than those for a pharmacy. 2. “Staffing requirements”: an LSP does not need to employ a full-time registered pharmacist; it only needs to ensure that staff have completed a training course recognised by the Pharmacy and Poisons Board (PPB), substantially reducing staffing costs. 3. “Premises requirements”: although the relevant medicines must be stored securely, the fit-out and layout requirements are not as stringent as those for a pharmacy, and a dedicated dispensing area is not required. It is therefore often an option for convenience stores, supermarkets or dispensaries selling non-prescription medicines.

📘 Regulatory basis

Under the Pharmacy and Poisons Regulations, Listed Sellers of Poisons may sell only Part II poisons, and they must be sold in sealed containers in their original packaging. A pharmacy may sell Part I and Part II poisons and handle doctors’ prescriptions.

📗 Drew Tang's recommendations

For investors wishing to enter pharmaceutical retail on a limited budget, or businesses such as supermarkets seeking to add medicine sales to their existing retail operations, Listed Seller of Poisons (LSP) status offers a highly cost-effective entry point. However, you must understand the limitations of its scope of operation: it does not permit the sale of any prescription medicines.

📕 Risk notice

The greatest risk is “operating beyond the permitted scope”. A Listed Seller of Poisons (LSP) selling prescription medicines or repackaging medicines for retail sale would be committing a serious offence. Staff must be trained rigorously to ensure they know which medicines may be sold and which must never be handled, avoiding breaches of the law through ignorance.

Back to Category F: Fees, Budget and Financial Planning (Q251-Q300) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗